EP3585396A4 - Compounds, compositions and methods for prevention or treatment of liver, lipid, and glucose-related conditions - Google Patents
Compounds, compositions and methods for prevention or treatment of liver, lipid, and glucose-related conditions Download PDFInfo
- Publication number
- EP3585396A4 EP3585396A4 EP18756987.6A EP18756987A EP3585396A4 EP 3585396 A4 EP3585396 A4 EP 3585396A4 EP 18756987 A EP18756987 A EP 18756987A EP 3585396 A4 EP3585396 A4 EP 3585396A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- lipid
- liver
- glucose
- prevention
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762461678P | 2017-02-21 | 2017-02-21 | |
PCT/US2018/018806 WO2018156513A1 (en) | 2017-02-21 | 2018-02-20 | Compounds, compositions and methods for prevention or treatment of liver, lipid, and glucose-related conditions |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3585396A1 EP3585396A1 (en) | 2020-01-01 |
EP3585396A4 true EP3585396A4 (en) | 2020-11-25 |
Family
ID=63252985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18756987.6A Withdrawn EP3585396A4 (en) | 2017-02-21 | 2018-02-20 | Compounds, compositions and methods for prevention or treatment of liver, lipid, and glucose-related conditions |
Country Status (3)
Country | Link |
---|---|
US (1) | US20200009169A1 (en) |
EP (1) | EP3585396A4 (en) |
WO (1) | WO2018156513A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109679946B (en) * | 2019-01-04 | 2020-11-13 | 宁波艾捷康宁生物科技有限公司 | Blood virus RNA protective agent and blood collection tube |
CN111700902B (en) * | 2020-07-16 | 2022-02-22 | 河北农业大学 | Hawthorn procyanidine-jujube polysaccharide composition and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120276208A1 (en) * | 2011-04-27 | 2012-11-01 | University Of South Australia | Acute cognitive and mood effects of plant polysaccharides in adult human subjects |
WO2017023703A1 (en) * | 2015-07-31 | 2017-02-09 | Sivanaray, Inc. | Compounds, compositions and methods for prevention or treatment of liver and lipid-related conditions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100438878C (en) * | 2002-08-30 | 2008-12-03 | 中国科学院上海有机化学研究所 | Active largehead atractylodes saccharide complex for reducing blood sugar and its prepn and use |
KR100544052B1 (en) * | 2003-10-31 | 2006-01-23 | 주식회사 엠디바이오알파 | Polysaccharides Of Plants Belonging To Panax Having Effect On Treatment And Prevention Of Obesity |
CN105326880A (en) * | 2015-11-25 | 2016-02-17 | 江苏康缘药业股份有限公司 | Rape pollen water soluble extract as well as preparation method and application thereof |
-
2018
- 2018-02-20 WO PCT/US2018/018806 patent/WO2018156513A1/en unknown
- 2018-02-20 EP EP18756987.6A patent/EP3585396A4/en not_active Withdrawn
- 2018-02-20 US US16/487,829 patent/US20200009169A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120276208A1 (en) * | 2011-04-27 | 2012-11-01 | University Of South Australia | Acute cognitive and mood effects of plant polysaccharides in adult human subjects |
WO2017023703A1 (en) * | 2015-07-31 | 2017-02-09 | Sivanaray, Inc. | Compounds, compositions and methods for prevention or treatment of liver and lipid-related conditions |
Non-Patent Citations (2)
Title |
---|
INOUE S ET AL: "EFFECT OF L-ARABINOSE ON BLOOD GLUCOSE LEVEL AFTER INGESTION OF SUCROSE-CONTAINING FOOD IN HUMAN", NIPPON EIYO SHOKURYO GAKKAISHI - JOURNAL OF JAPANESE SOCIETY OFNUTRITION AND FOOD SCIENCE, TOKYO, JP, vol. 53, no. 6, 1 January 2000 (2000-01-01), pages 243 - 247, XP002906378, ISSN: 0287-3516 * |
See also references of WO2018156513A1 * |
Also Published As
Publication number | Publication date |
---|---|
US20200009169A1 (en) | 2020-01-09 |
EP3585396A1 (en) | 2020-01-01 |
WO2018156513A1 (en) | 2018-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3679141A4 (en) | Methods and compositions for inhibiting expression of ldha | |
EP3481402A4 (en) | Compounds, compositions, and methods for the treatment of disease | |
EP3675859A4 (en) | Compounds, compositions, and methods for the treatment of disease | |
EP3294761A4 (en) | Compositions and methods for treatment and prevention of uropathogenice. coli | |
EP3810109A4 (en) | Compositions and methods for inhibiting cd73 | |
EP3399993A4 (en) | Methods and compositions for the prevention and treatment of duchenne muscular dystrophy | |
EP3426349A4 (en) | Methods and compositions for inhibiting pmp22 expression | |
EP3471722A4 (en) | Compounds, compositions and methods for prevention and/or treatment of cancer | |
EP3720421A4 (en) | Compositions and methods for the treatment of metabolic conditions | |
EP3675858A4 (en) | Compounds and compositions for ire1 inhibition | |
EP3310783A4 (en) | Methods and compositions for the prevention and treatment of hearing loss | |
EP3445450A4 (en) | Method of treating or preventing liver conditions | |
EP3236993A4 (en) | Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics | |
EP3344256A4 (en) | Compositions for the treatment of joints | |
EP3522899A4 (en) | Compounds and compositions for treating leishmaniasis and methods of diagnosis and treating using same | |
EP3687628A4 (en) | Compositions and methods for inhibiting acss2 | |
EP3675632A4 (en) | Methods and compositions for the preservation of tissue | |
EP3391881A4 (en) | Pharmaceutical composition for preventing or treating fatty liver | |
EP3203999A4 (en) | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis | |
EP3341006A4 (en) | Compositions and methods for the treatment of neurodamage | |
EP3277269A4 (en) | Methods for prevention and treatment of cardiometabolic syndrome and compositions used therein | |
EP3203992A4 (en) | Compositions and methods for increasing the bioavailability of one or more compounds | |
EP3618846A4 (en) | Methods and compositions for treating liver disease | |
EP3328392A4 (en) | Compounds, compositions and methods for prevention or treatment of liver and lipid-related conditions | |
EP3585396A4 (en) | Compounds, compositions and methods for prevention or treatment of liver, lipid, and glucose-related conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20190920 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20201028 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 3/10 20060101ALI20201022BHEP Ipc: A61K 9/20 20060101ALI20201022BHEP Ipc: A61K 9/48 20060101ALI20201022BHEP Ipc: A61K 31/7004 20060101ALI20201022BHEP Ipc: A61K 31/7012 20060101AFI20201022BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20210528 |